McMurry-Heath Michelle

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
McMurry-Heath Michelle's trades of Bioventus Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-13 2026-03-11 S Sale
42,609 +18.9%
242.92
US$1,405,998
42,609 +18.9% 242.92 US$1,405,998
2026-03-11 2026-03-11 PrS Proposed sale
30,989
268.91
US$2,774,878
30,989 268.91 US$2,774,878
2026-02-25 2026-02-23 S Sale
93,389 -6.7%
204.84
US$1,198,381
93,389 -6.7% 204.84 US$1,198,381
2026-02-23 2026-02-23 PrS Proposed sale
600
97.26
US$58,353
600 97.26 US$58,353
2025-11-10 2025-11-07 S Sale
17,701 -23.7%
7.42
US$131,255
17,701 -23.7% 7.42 US$131,255
2025-11-07 2025-11-07 PrS Proposed sale
27,000
7.41
US$200,041
27,000 7.41 US$200,041
2025-05-30 2025-05-29 S Sale
600 -11.0%
92.17
US$55,299
600 -11.0% 92.17 US$55,299
2025-05-29 2025-05-29 PrS Proposed sale
600
92.17
US$55,299
600 92.17 US$55,299
2025-02-07 2025-02-06 S Sale
1,970 -39.5%
119.49
US$235,395
1,970 -39.5% 119.49 US$235,395
2025-02-06 2025-02-06 PrS Proposed sale
1,970
119.49
US$235,395
1,970 119.49 US$235,395